DCPH Shares Outstanding History



Below is a table of the DCPH shares outstanding history going back to 9/28/2017:

Date DCPH Shares Outstanding
9/28/201730.68M
10/31/201732.59M
2/28/201832.59M
4/30/201832.59M
7/31/201837.66M
10/31/201837.66M
2/28/201938.19M
4/30/201938.19M
6/30/201938.22M
9/30/201951.04M
2/28/202055.65M
4/30/202055.86M
7/31/202056.38M
10/30/202056.93M
1/31/202157.63M
4/30/202157.96M
7/30/202158.04M
10/29/202158.48M
1/31/202258.55M
4/29/202266.22M
7/29/202266.82M
10/28/202267.58M
1/31/202375.95M
4/28/202378.52M
7/28/202378.82M
10/26/202380.12M
1/31/202480.80M

Also see: DCPH Market Cap History
DCPH YTD Return
DCPH Historical Shares Outstanding:
+16.49% CAGR
DCPH Historical Shares Outstanding: +16.49% CAGR

Mouse over chart for data details
9/28/2017 ...1/31/2024
Deciphera Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing medicines to improve the lives of people with cancer. Using its proprietary switch-control kinase inhibitor platform and capabilities in kinase biology, Co. designs kinase inhibitors to target the switch pocket region of the kinase with the goal of developing medicines. QINLOCK, Co.'s switch-control kinase inhibitor, was developed using Co.'s proprietary drug discovery platform and developed for the treatment of fourth-line gastrointestinal stromal tumor. Co. has developed a pipeline of drug candidates, including vimseltinib and DCC-3116. We show 27 historical shares outstanding datapoints in our coverage of DCPH's shares outstanding history.

Understanding the changing numbers of DCPH shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like DCPH versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching DCPH by allowing them to research DCPH shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree DCPH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Deciphera Pharmaceuticals (DCPH) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

DCTH Shares Outstanding History
DEPO Shares Outstanding History
DERM Shares Outstanding History
DFFN Shares Outstanding History
DGX Shares Outstanding History
DHR Shares Outstanding History
DICE Shares Outstanding History
DMK Shares Outstanding History
DMPI Shares Outstanding History
DMTK Shares Outstanding History
More Healthcare companies »

 

DCPH Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.